AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2025

Jun 6, 2025

31949_dirs_2025-06-06_77534ab4-e3e1-4c49-a6f9-be28ed0efd59.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2025-06-04

Reporting Person: Leonard Frank X (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-04	Ordinary Shares	A	179426.00	$0.00	Acquired	347878.00	Direct

Footnotes

F1: Represents restricted share units that are scheduled to vest in equal installments on June 4, 2026 and 2027, subject to the reporting person's continued employment through such dates.